Show simple item record

dc.contributor.authorMudge, S
dc.contributor.authorStott, S
dc.contributor.authorWalt, S
dc.date.accessioned2013-05-21T03:15:22Z
dc.date.available2013-05-21T03:15:22Z
dc.date.copyright2007
dc.date.issued2013-05-21
dc.identifier.citationArchives of Physical Medicine and Rehabilitation, vol.88, pp.1710 - 1715
dc.identifier.urihttp://hdl.handle.net/10292/5354
dc.description.abstractObjectives To test the validity of the StepWatch Activity Monitor (SAM) in subjects with stroke against 2 criterion standards, 3-dimensional gait analysis (3-DGA) and footswitches in a variety of indoor and outdoor walking conditions, including different speeds and different terrains, and to test the accuracy of the SAM when worn on the paretic limb. Design Criterion standard validation study. Setting Gait laboratory and outside course. Participants Twenty-five participants with physical disability after stroke. Interventions Not applicable. Main Outcome Measures The total step count measured simultaneously by SAM and either 3-DGA or footswitches for both paretic and nonparetic limbs. Results The total step count measured by the SAM and 3-DGA was highly correlated (nonparetic limb, r=.959; paretic limb, r=.896). The 95% limits of agreement (LOA) (derived from Bland-Altman analysis) between the SAM and 3-DGA were within ±10 steps for SAMs worn on either the nonparetic or paretic limb. The total step count measured simultaneously by the SAM and footswitches was also highly correlated for each limb (nonparetic, r=.999; paretic, r=.963). The 95% LOA between the SAM and footswitches were ±9 steps on the nonparetic limb but higher at ±57 steps on the paretic limb. Further analysis showed that the measurement differences occurred during the outdoor component of the combined walk. The 95% LOA between footswitches on both limbs were not more than ±9 steps for walking, suggesting that the error was accounted for by the SAM on the paretic limb, which both over- and underread the total step count in the outdoor walking conditions. Conclusions Criterion validity of the SAM to measure steps in both clinical and natural environments has been established when used on the nonparetic limb. However, more errors are apparent when the SAM is worn on the paretic limb while walking over a variety of outdoor terrains. Validation is recommended before use in patients with neurologic conditions affecting bilateral legs because there may be more error, particularly in outdoor activities.
dc.publisherElsevier
dc.rightsCopyright © 2007 Elsevier Ltd. All rights reserved. This is the author’s version of a work that was accepted for publication in (see Citation). Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. The definitive version was published in (see Citation). The original publication is available at (see Publisher's Version).
dc.subjectCerebrovascular accident
dc.subjectGait
dc.subjectMotor activity
dc.subjectRehabilitation
dc.titleCriterion validity of the StepWatch Activity Monitor as a measure of walking activity in individuals following stroke
dc.typeJournal Article
dc.rights.accessrightsOpenAccess
dc.identifier.doi10.1016/j.apmr.2007.07.039
dc.identifier.roid11999en_NZ
aut.relation.endpage1715
aut.relation.startpage1710
aut.relation.volume88
pubs.elements-id14144


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record